The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
Zacks.com on MSN1d
FTC Report Reveals PBM Practices Impacting Competition and Drug CostsThe FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
JERSEY CITY, N.J., Jan. 16, 2025 /PRNewswire/ -- Outcomes Matter Innovations, LLC ("OMI") today announced the addition of ...
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to ...
"They're helping patients kind of manage through the treatment paradigm with respect to which drugs to take, which formulary drugs are on, and kind of managing that whole process. So there is a ...
Wegovy and Ozempic are weight loss drugs that promise to transform the treatment of obesity ... The price at which the PBM obtains the drug for its clients is the net price—the list price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback